dacarbazine has been researched along with caffeic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jablonska-Trypuo, A; Kalinowska, M; Lewandowsk, W; Matejczyk, M; Swidersk, G; Swislocka, R | 1 |
| Assmann, CE; Bagatini, MD; da Cruz, IBM; de Andrade, CM; de Oliveira Alves, A; Mânica, A; Morsch, VMM; Palma, TV; Pelinson, LP; Pillat, MM; Schetinger, MRC; Stefanello, N; Ulrich, H; Weis, GCC | 1 |
2 other study(ies) available for dacarbazine and caffeic acid
| Article | Year |
|---|---|
MONITORING OF SYNERGISTIC ENHANCEMENT OF CAFFEIC ACID ON ESCHERICHIA COLI K-12 RECA::GFP STRAIN TREATED WITH DACARBAZINE.
Topics: Antineoplastic Agents; Caffeic Acids; Dacarbazine; DNA Damage; DNA, Bacterial; Drug Synergism; Escherichia coli K12; Gene Expression Regulation, Bacterial; Genes, Reporter; Green Fluorescent Proteins; Microbial Viability; Promoter Regions, Genetic; Rec A Recombinases; Spectrometry, Fluorescence; Time Factors | 2017 |
Antiproliferative and apoptotic effects of caffeic acid on SK-Mel-28 human melanoma cancer cells.
Topics: Adult; Antineoplastic Agents; Apoptosis; Caffeic Acids; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Female; Healthy Volunteers; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Skin Neoplasms | 2019 |